The clinical and biological significance of HER2 over-expression in breast ductal carcinoma in situ: a large study from a single institution

BACKGROUND: Previous studies have reported up to 50% of ductal carcinoma in situ (DCIS), is HER2 positive, but the frequency of HER2-positive invasive breast cancer (IBC) is lower. The aim of this study is to characterise HER2 status in DCIS and assess its prognostic value. METHODS: HER2 status was...

Descripción completa

Detalles Bibliográficos
Autores principales: Miligy, Islam M., Toss, Michael S., Gorringe, Kylie L., Lee, Andrew H. S., Ellis, Ian O., Green, Andrew R., Rakha, Emad A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6738110/
https://www.ncbi.nlm.nih.gov/pubmed/31065110
http://dx.doi.org/10.1038/s41416-019-0436-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6738110/
https://www.ncbi.nlm.nih.gov/pubmed/31065110
http://dx.doi.org/10.1038/s41416-019-0436-3

Ejemplares similares